|
1
|
Cordes C, Hasler R, Werner C, Gorogh T, et
al: The level of secretory leukocyte protease inhibitor is
decreased in metastatic head and neck squamous cell carcinoma. Int
J Oncol. 39:185–191. 2011.PubMed/NCBI
|
|
2
|
Hoffmann M, Ihloff AS, Gorogh T, et al:
p16(INK4a) overexpression predicts translational active human
papillomavirus infection in tonsillar cancer. Int J Cancer.
127:1595–1602. 2010. View Article : Google Scholar
|
|
3
|
Kreimer AR, Clifford GM, Boyle P, et al:
Human papillomavirus types in head and neck squamous cell
carcinomas worldwide: a systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith EM, Ritchie JM, Summersgill KF, et
al: Age, sexual behavior and human papillomavirus infection in oral
cavity and oropharyngeal cancers. Int J Cancer. 108:766–772. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Termine N, Panzarella V, Falaschini S, et
al: HPV in oral squamous cell carcinoma vs head and neck squamous
cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol.
19:1681–1690. 2008.PubMed/NCBI
|
|
6
|
Hafkamp HC, Manni JJ, Haesevoets A, et al:
Marked differences in survival rate between smokers and nonsmokers
with HPV 16-associated tonsillar carcinomas. Int J Cancer.
122:2656–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoffmann M, Gottschlich S, Gorogh T, et
al: Human papillomaviruses in lymph node neck metastases of head
and neck cancers. Acta Otolaryngol. 125:415–421. 2005.PubMed/NCBI
|
|
8
|
Hoffmann M, Gorogh T, Gottschlich S, et
al: Human papillomaviruses in head and neck cancer: 8
year-survival-analysis of 73 patients. Cancer Lett. 218:199–206.
2005.PubMed/NCBI
|
|
9
|
Drannik AG, Henrick BM and Rosenthal KL:
War and peace between WAP and HIV: role of SLPI, trappin-2, elafin
and ps20 in susceptibility to HIV infection. Biochem Soc Trans.
39:1427–1432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fakioglu E, Wilson SS, Mesquita PM, et al:
Herpes simplex virus downregulates secretory leukocyte protease
inhibitor: a novel immune evasion mechanism. J Virol. 82:9337–9344.
2008. View Article : Google Scholar
|
|
11
|
Boudier C, Cadene M and Bieth JG:
Inhibition of neutrophil cathepsin G by oxidized mucus proteinase
inhibitor. Effect of heparin. Biochemistry. 29:8451–8457. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abe T, Kobayashi N, Yoshimura K, et al:
Expression of the secretory leukoprotease inhibitor gene in
epithelial cells. J Clin Invest. 87:2207–2215. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franken C, Meijer CJ and Dijkman JH:
Tissue distribution of antileukoprotease and lysozyme in humans. J
Histochem Cytochem. 37:493–498. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin FY, Nathan C, Radzioch D and Ding A:
Secretory leukocyte protease inhibitor: a macrophage product
induced by and antagonistic to bacterial lipopolysaccharide. Cell.
7:417–426. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hiemstra PS: Novel roles of protease
inhibitors in infection and inflammation. Biochem Soc Trans.
30:116–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ang KK, Harris J, Wheeler R, et al: Human
papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cole L, Polfus L and Peters ES: Examining
the incidence of human papillomavirus-associated head and neck
cancers by race and ethnicity in the U.S., 1995–2005. PLoS One.
7:e326572012.PubMed/NCBI
|
|
18
|
Chan KH, Chan SC, Yeung SC, et al:
Inhibitory effect of Chinese green tea on cigarette smoke-induced
up-regulation of airway neutrophil elastase and matrix
metalloproteinase-12 via antioxidant activity. Free Radic Res.
46:1123–1129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoffmann M, Tribius S, Quabius ES, et al:
HPV DNA, E6(*)I-mRNA expression and p16(INK4A) immunohistochemistry
in head and neck cancer - how valid is p16(INK4A) as surrogate
marker? Cancer Lett. 323:88–96. 2012.
|
|
20
|
Remmerbach TW, Brinckmann UG, Hemprich A,
et al: PCR detection of human papillomavirus of the mucosa:
comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol.
30:302–308. 2004.PubMed/NCBI
|
|
21
|
Schmitt M, Bravo IG, Snijders PJ, et al:
Bead-based multiplex genotyping of human papillomaviruses. J Clin
Microbiol. 44:504–512. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmitt M, Dondog B, Waterboer T, et al:
Homogeneous amplification of genital human alpha papillomaviruses
by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin
Microbiol. 46:1050–1059. 2008.PubMed/NCBI
|
|
23
|
Halec G, Schmitt M, Dondog B, et al:
Biological activity of probable/possible high-risk human
papillomavirus types in cervical cancer. Int J Cancer. 132:63–71.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McNeely TB, Shugars DC, Rosendahl M, et
al: Inhibition of human immunodeficiency virus type 1 infectivity
by secretory leukocyte protease inhibitor occurs prior to viral
reverse transcription. Blood. 90:1141–1149. 1997.
|
|
25
|
Woodham AW, Da Silva DM, Skeate JG, et al:
The S100A10 subunit of the annexin A2 heterotetramer facilitates
L2-mediated human papillomavirus infection. PLoS One. 7:e435192012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wahl SM, McNeely TB, Janoff EN, et al:
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids
inhibits HIV-I. Oral Dis. 3(Suppl 1): S64–S69. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Z and Yang P: Role of imbalance
between neutrophil elastase and alpha 1-antitrypsin in cancer
development and progression. Lancet Oncol. 5:182–190. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakamura K, Takamoto N, Hongo A, et al:
Secretory leukoprotease inhibitor inhibits cell growth through
apoptotic pathway on ovarian cancer. Oncol Rep. 19:1085–1091.
2008.PubMed/NCBI
|
|
29
|
Alkemade HA, van Vlijmen-Willems IM, van
Haelst UJ, et al: Demonstration of skin-derived antileukoproteinase
(SKALP) and its target enzyme human leukocyte elastase in squamous
cell carcinoma. J Pathol. 174:121–129. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Westin U, Nystrom M, Ljungcrantz I, et al:
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and
neck squamous cell carcinomas and their relation to the degree of
tumour differentiation. Mediators Inflamm. 11:7–12. 2002.
View Article : Google Scholar : PubMed/NCBI
|
